Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Goodwill & Intangibles (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Goodwill & Intangibles for 16 consecutive years, with $9.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 83.04% to $9.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $9.7 million, a 83.04% decrease, with the full-year FY2024 number at $114.8 million, down 0.82% from a year prior.
  • Goodwill & Intangibles was $9.7 million for Q3 2025 at Harvard Bioscience, down from $70.3 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $120.0 million in Q2 2022 to a low of $9.0 million in Q1 2025.
  • A 5-year average of $72.3 million and a median of $58.4 million in 2021 define the central range for Goodwill & Intangibles.
  • Peak YoY movement for Goodwill & Intangibles: skyrocketed 105.32% in 2022, then tumbled 84.2% in 2025.
  • Harvard Bioscience's Goodwill & Intangibles stood at $85.1 million in 2021, then dropped by 9.17% to $77.3 million in 2022, then surged by 49.76% to $115.7 million in 2023, then dropped by 0.82% to $114.8 million in 2024, then crashed by 91.51% to $9.7 million in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Goodwill & Intangibles are $9.7 million (Q3 2025), $70.3 million (Q2 2025), and $9.0 million (Q1 2025).